BRÈVE

sur MicroGenDX

MicroGenDX Launches New Patient-Focused Website to Enhance Access to Microbial Testing

MicroGenDX, the leader in clinical Next Generation DNA Sequencing (NGS) tests, announced the launch of a redesigned website aimed at improving patient access to microbial diagnostic products. This new platform is developed with a strong patient-centric approach to simplify the discovery and understanding of medical tests.

The website facilitates users to navigate and opt for microbial testing relevant to both clinical diagnosis and lifestyle purposes. With the aim of reducing the complexity of medical diagnostics, the site includes enhanced navigation that allows users to learn about, select, and receive their tests in as few as three clicks. This effort underscores MicroGenDX's commitment to providing user-friendly digital tools that empower patients with knowledge about their health options.

The design of the website focuses on streamlining patient experiences during test selection and purchase, offering comprehensive education materials, and simplifying test collection and submission processes. This transformation marks MicroGenDX’s expansion of its services into direct-to-patient applications, addressing a broad range of microbial testing requirements.

R. H.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de MicroGenDX